Abstract
<p>Figure S2 Figure S2. Flowchart of the exome analysis. The cohort is composed of 77 patients; 65 have matched tumour and normal exomes, and 12 have only a tumour exome. When matched exomes are available, single-nucleotide variants, polymorphisms, mutational signatures, ploidy, large loss of heterozygosity (LOH) and deletions, copy number alteration (CNA) clonality, neoantigens, and T-cell receptor (TCR) clonality were analysed. TRC clonality could also be estimated for patients with a tumour exome only</p>
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
